医学
指南
血压
疾病
重症监护医学
临床试验
内科学
随机对照试验
降低血压
认知障碍
梅德林
儿科
疾病管理
抵抗性高血压
标识
DOI:10.7326/annals-26-01311
摘要
Updated U.S. and international hypertension guidelines reflect new studies and analyses that support changes in hypertension management. The 2025 U.S. guideline for prevention, detection, evaluation, and management of high blood pressure (BP) recommends lower BP targets, greater use of out-of-office BP for diagnosis and medication titration, and a different approach to severe hypertension presenting without acute or evolving cardiovascular disease symptoms or signs. New treatments for resistant hypertension are recommended. Trial evidence supports benefit from tighter BP control to prevent mild cognitive impairment and dementia, further emphasizing the importance of lower BP goals.
科研通智能强力驱动
Strongly Powered by AbleSci AI